Cramer says that he's keeping an eye on Pfizer. "I'm more inclined to buy Pfizer, Pfizer offloads these low multiples, these low a low margin drugs and Pfizer's down. That's wrong," said Cramer.
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.” He added, “I can't believe the stock dropped so much.” ...
Jim Cramer has been focused on cruise stocks for the past couple of weeks. "For his second "Executive Decision" segment, Cramer also spoke with Frank Del Rio, president and CEO of Norwegian Cruise ...